Company intelligence / Profile preview
ArrayPatch
- Ownership
- Private
- Development stage
- Preclinical
Overview
ArrayPatch is developing a proprietary microneedle-based drug delivery technology called DerMap. Their first product, ITZ-DerMap, is being developed for the treatment of onychomycosis (nail fungal infection). The company has won several awards including Innovation of the Year at the Pharma Industry Awards 2022 and the 2023 IDEATE Ireland competition.
- Therapeutic areas
- OncologyEndocrinologyDermatologyNeurologyInfectious Diseases
- Modalities
- Microneedle-based drug delivery technology
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on ArrayPatch.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ArrayPatch.